Hanson McClain Advisors »

Cidara Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $430 40 10.75
2024-06-30 $473 40 11.83

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Cidara Therapeutics

RA Capital Management
BVF
Monashee Investment Management
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
Geode Capital Management
BlackRock
BlackRock
Northern Trust
Schonfeld Strategic Advisors
State Street Corporation
Russell Investments

View all funds holding Cidara Therapeutics